{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:52:59Z","timestamp":1778561579959,"version":"3.51.4"},"reference-count":6,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Dermatol Venereol Leprol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijdvl.ijdvl_918_19","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T12:55:25Z","timestamp":1603889725000},"page":"688","source":"Crossref","is-referenced-by-count":7,"title":["Ponatinib-induced atypical pityriasis rubra pilaris-like rash"],"prefix":"10.25259","volume":"86","author":[{"given":"Rahul","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debajyoti","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"key-10.4103\/0378-6323.299494-1","first-page":"574","volume-title":"Ponatinib-induced pityriasiform, folliculocentric and ichthyosiform cutaneous toxicities","author":"Alloo","year":"2015","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0378-6323.299494-2","first-page":"e519","volume-title":"Ponatinib-induced widespread ichthyosiform eruption","author":"Derlino","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0378-6323.299494-3","first-page":"393","volume-title":"Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: Final 5-year results of the phase 2 PACE trial","author":"Cortes","year":"2018","journal-title":"Blood"},{"key":"key-10.4103\/0378-6323.299494-4","first-page":"19","volume-title":"Ichthyosiform pityriasis rubra pilaris-like Eruption Secondary to Ponatinib Therapy: Case report and literature review","author":"Eber","year":"2017","journal-title":"Drug Saf Case Rep"},{"key":"key-10.4103\/0378-6323.299494-5","first-page":"e249","volume-title":"Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib","author":"Jack","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0378-6323.299494-6","first-page":"391","volume-title":"Retinoid chemoprevention: Who can benefit?","author":"Bunaciu","year":"2015","journal-title":"Curr Pharmacol Rep"}],"container-title":["Indian Journal of Dermatology, Venereology and Leprology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T10:40:56Z","timestamp":1611916856000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijdvl.com\/ponatinib-induced-atypical-pityriasis-rubra-pilaris-like-rash\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"alternative-id":["299494"],"URL":"https:\/\/doi.org\/10.4103\/ijdvl.ijdvl_918_19","relation":{},"ISSN":["0378-6323"],"issn-type":[{"value":"0378-6323","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}